We’re offering a special edition of Zedmed for free during the Covid-19 outbreak to enable practices to use the new ePrescribing functionality. Read on for more information and to register for access.
This special release is based on the Zedmed Version 32, and focuses on providing practices with access to the brand new ePrescribing function. Originally this functionality was to be made available towards the end of 2020, however the Covid-19 outbreak and subsequent lockdown measures prompted the ADHA, in conjunction with the Federal Government, to implement a fast-track program to bring ePrescribing to market as soon as possible. We’re now offering this functionality, free of charge, to practices who don’t yet have access to ePrescribing functionality or who have previously been paper based.
The medical industry is currently in the early stages of the rollout of ePrescribing. In order to accelerate the delivery of ePrescribing, industry participants across all points of the prescribing chain have collaborated alongside various Government and peak bodies to deliver a complete solution.
It is important to note that while ePrescribing is progressively being rolled out across medical practices and pharmacies, it is not an immediate process. There will be a transitionary period of time when dispensing software is still to be updated at many pharmacies, and many patients will be unaware of the ePrescribing option. We therefore encourage any practice looking to utilise ePrescribing to communicate with their nearby pharmacies to understand their readiness, and talk to their patients to inform them of this option.
Any practice or individual who registers for the free edition can receive it. Due to legislative restrictions, we will send make it available first to Vic and NSW, and then to the other states as this becomes possible.
You will need a MIMS subscription to access the drugs database (mims.com.au), and you will need to be connected to either of the prescription exchanges (eRx or Medisecure). Zedmed will cover the cost of the MIMS subscription.
We haven’t set a hard date for when we will deactivate this version of Zedmed, it will be based on the ending of the Covid-19 outbreak and the easing of lockdown restrictions. We will give you notice for when we can put a date to this, and provide options for continuing use of Zedmed if you wish to.